In Europe, approximately 250 people ages 6 and older have one of 8 additional gating mutations- KALYDECO is the first medicine to treat the underlying …
In Europe, approximately 250 people ages 6 and older have one of 8 additional gating mutations- KALYDECO is the first medicine to treat the underlying …